A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients()

BACKGROUND/AIMS: Interferon and ribavirin combination therapy for chronic hepatitis C induces a low response rate in human immunodeficiency virus (HIV) infected patients. To assess the impact of intensification of interferon administration and of the addition of amantadine on the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Puoti, Massimo, Zanini, Barbara, Quinzan, Gian Paolo, Ravasio, Laura, Paraninfo, Giuseppe, Santantonio, Teresa, Rollo, Adriano, Artioli, Stefania, Maggiolo, Franco, Zaltron, Serena, MASTER HIV/HCV Co-infection study group, Raise, Enzo, Mignani, Ermenegildo, Resta, Francesco, Verucchi, Gabriella, Pastore, Giuseppe, Suter, Fredy, Carosi, Giampiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. 2004
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126192/
https://www.ncbi.nlm.nih.gov/pubmed/15288482
http://dx.doi.org/10.1016/j.jhep.2004.04.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126192/
https://www.ncbi.nlm.nih.gov/pubmed/15288482
http://dx.doi.org/10.1016/j.jhep.2004.04.016

Ejemplares similares